» Articles » PMID: 20946557

P-wave Indices: Derivation of Reference Values from the Framingham Heart Study

Overview
Date 2010 Oct 16
PMID 20946557
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

Background: P-wave indices, an electrocardiographic phenotype reflecting atrial electrophysiology and morphology, may be altered in multiple disease states or by cardiovascular risk factors. Reference values for P-wave indices, providing cut points for their classification and interpretation, have not yet been established and are essential toward facilitating clinical application and comparison between studies.

Methods: We randomly selected 20 men and 20 women from 10-year age intervals between <25 years to 76-85 years from the Framingham Heart Study Original and Offspring Cohorts, excluding subjects with prevalent cardiovascular disease, hypertension, diabetes or obesity. The total included 295 subjects; eligibility in women >75 years was limited by exclusion criteria. We used a digital measurement technique with demonstrated intrarater reproducibility to determine P-wave indices. P-wave indices examined included the maximum, mean, lead II and PR durations, dispersion, and the standard deviation of duration.

Results: All P-wave indices were significantly (P < 0.0001) correlated with advancing age. Means of all P-wave indices were lower in women as compared to men. PR-interval duration was strongly correlated with maximum, mean, and lead II mean P-wave durations. In multivariable models adjusting for significant anthropometric and clinical associations risk factors, significant differences persisted by age and sex in P-wave indices.

Conclusions: In our healthy sample without cardiovascular disease, hypertension, diabetes, or obesity, men and older subjects had longer mean P-wave indices. Our description of P-wave indices establishes reference values for future comparative studies and facilitates the classification of P-wave indices.

Citing Articles

The Effect of Glycemic Status on P Wave Dispersion.

Ragavan N, Thavalam R, Moorthy S Cureus. 2024; 16(4):e58233.

PMID: 38745813 PMC: 11092425. DOI: 10.7759/cureus.58233.


New electrocardiographic aspects of the P wave: Its value in clinical cardiology.

Bayes-de-Luna A, Bacharova L Ann Noninvasive Electrocardiol. 2023; 28(3):e13053.

PMID: 36825831 PMC: 10196095. DOI: 10.1111/anec.13053.


Increased P-wave dispersion in patients with obstructive sleep apnea syndrome: a meta-analysis.

Kelmanson I Sleep Breath. 2022; 27(1):291-301.

PMID: 35501617 DOI: 10.1007/s11325-022-02630-1.


The immediate trends in atrial electrical remodeling for paroxysmal atrial fibrillation across different modes of catheter ablation.

Hou Q, Feng L, Yang J, Liu Y, You L, Wang L Clin Cardiol. 2021; 44(7):938-945.

PMID: 34061373 PMC: 8259153. DOI: 10.1002/clc.23617.


Assessment of Hypertension Using Clinical Electrocardiogram Features: A First-Ever Review.

Bird K, Chan G, Lu H, Greeff H, Allen J, Abbott D Front Med (Lausanne). 2020; 7:583331.

PMID: 33344473 PMC: 7746856. DOI: 10.3389/fmed.2020.583331.


References
1.
Levy D, Larson M, Vasan R, Kannel W, Ho K . The progression from hypertension to congestive heart failure. JAMA. 1996; 275(20):1557-62. View

2.
Kligfield P, Badilini F, Brown B, Helfenbein E, Kohls M . The ISCE ECG genome pilot challenge: a 2004 progress report. J Electrocardiol. 2004; 37 Suppl:144-8. DOI: 10.1016/j.jelectrocard.2004.08.039. View

3.
Duru M, Seyfeli E, Kuvandik G, Kaya H, Yalcin F . Effect of weight loss on P wave dispersion in obese subjects. Obesity (Silver Spring). 2006; 14(8):1378-82. DOI: 10.1038/oby.2006.156. View

4.
Sagie A, Larson M, Goldberg R, Bengtson J, Levy D . An improved method for adjusting the QT interval for heart rate (the Framingham Heart Study). Am J Cardiol. 1992; 70(7):797-801. DOI: 10.1016/0002-9149(92)90562-d. View

5.
Wolf P, DAgostino R, Belanger A, Kannel W . Probability of stroke: a risk profile from the Framingham Study. Stroke. 1991; 22(3):312-8. DOI: 10.1161/01.str.22.3.312. View